• Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues


Miltenyi Biotec Relocates-Expands Gaithersburg, Maryland, Headquarters

Global biotechnology business Miltenyi Biotec is relocating its operations in Gaithersburg, Maryland. The project is expected to create 130 new jobs by the end of 2022.

The company will expand its facility on 1201 Clopper Road to support additional manufacturing, research and development, quality assurance, and more. The expansion will bring the total number of employees to 300 in the state.

“Miltenyi Biotec’s decision to make Maryland its North American home is a testament to the strength of our life sciences industry as well as the supportive business climate we’ve established in our state,” said Maryland Commerce Secretary Mike Gill. “We’re thrilled the company has chosen to expand and create more good jobs in Maryland.”

To assist with job creation, the company has submitted a notice of intent to utilize the state’s More Jobs for Marylanders program and Job Creation Tax Credit, both managed by the Maryland Department of Commerce.

“The Montgomery County life sciences ecosystem encompasses a full range of biotech companies, including leading vector manufacturers like Miltenyi Biotec,” said Benjamin H. Wu, president & CEO of Montgomery County Economic Development Corporation. “Miltenyi Biotec is a global company on the rise, and we are delighted that they will continue advancing biomedical research and supporting cell and gene therapy from their Gaithersburg location.”

For more than 30 years, Miltenyi Biotec has focused on providing innovative products and services to support research throughout the biomedical and cellular therapy fields. With its global headquarters in Germany, Miltenyi Biotec has locations throughout Europe, Asia, Australia, and North America, and distributes its products to more than 50 countries. The company currently employs about 4,000 individuals around the world.

Exclusive Research